A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.
Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...
DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...
As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...
Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
Apple's high-yield Savings account, offered by Goldman Sachs, offers 4.40% APY on your savings. While that amount is more than 9 times the national average APY, it's not the highest rate available in ...